Investor Presentaiton

Innovent Academy and Key Drug Discovery Strategies Monoclonal antibodies Innovent Academy ● Objective: To develop and launch First-in-Class product globally as Innovent's powerful discovery engine • Key Therapeutic Focus: Oncology, metabolic diseases, immunology, and ophthalmology • Position: Global leading drug discovery platform for both scientific research and technology application • Structure: Immunology, Protein Antibody Engineering, Pharmacology, Translational Medicine and Cell Therapy Biology-driven, Technology-enabling (50+ drug discovery projects ongoing in Innovent Academy) Non-Oncology: Autoimmunity, Metabolic diseases, Ophthalmology Oncology: Immunotherapy and Targeted therapy Multi-specific antibodies ADC Cell Therapy Autoimmunity My fe Innovent Confidential Copyright©2021 Innovent Biologics Oge สว Metabolic diseases FATTY LIVER Ophthalmology Clary muse Celicne 33

View entire presentation